Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS Medicine

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1371/journal.pmed.0020073

License

CC-BY

Other Formats

PDF